Stock screener

NRIX

Conviction 96HealthcareScan · Thu, Jun 25, 2026
NRIX$22.43+16.22%
ResistanceSupportVol 14Insider sell
63 bars
2
2
Vol MA14 5.09M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Nurix Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.nurixtx.com ↗
Price22.43
Change+16.22%
Gap+0.47%
Rel volume4.46×
Avg volume3.91M
Avg $ vol68.6M
SMA 2017.16
SMA 5016.84
SMA 20015.28
Price vs 50+33.21%
Price vs 200+46.77%
MA stackbullish
50/200 cross—
Supertrendup · 16.88
RSI (14)81
MACD hist0.54
MACD crossbull · 8d
Stoch %K / %D93 / 92
ADX (14)27
+DI / −DI46 / 11
RSI divergence—
MACD divergence—
ATR %+5.98%
ADR %7.65%
52w high22.43
52w low8.24
From 52w high+0.00%
Above 52w low+172.21%
New 52w highYes
SqueezeOff
Bollinger width40.32%
%B1.26
Donchian pos93.02%
Donchian high23.05
Donchian low14.24
AVWAP (52w high)21.62
vs AVWAP high+3.74%
AVWAP (52w low)15.97
vs AVWAP low+40.42%
OBV trendUp
Chaikin MF (20)-0.17
Today vs 20d4.46×
Avg vol (14d)5.09M
Avg vol (20d)3.91M
Avg $ vol (20d)68.6M
Market cap2.32B
RS 3m (vs SPY)+21.40%
RS 6m (vs SPY)-3.52%
RS line new highYes
Trend template7/8
Technical rank89.4
1 week+31.02%
1 month+29.06%
3 months+45.27%
6 months+15.98%
1 year+87.39%
YTD+24.20%
P/E-8.77
P/B4.82
P/S27.62
P/FCF-8.80
EPS-3.05
Div yield—
ROE-54.99%
ROA-41.57%
Debt/Eq—
Current6.01
EV/EBITDA-8.12
Gross margin—
Net margin-314.90%
Rev growth53.95%
EPS growth-36.62%
Price target33.00
Target upside47.12%
Analyst ratingBuy
Institutional119.52%
Ent. value2.25B
Revenue6.25M
Net income-87.17M
Gross profit—
Free cash flow-263.47M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out103.41M
Employees357
ListedFri, Jul 24, 2020
Free float97.8M
Float %94.6%
Short interest19.32M
Days to cover14.9d
Short volume36.3%
Squeeze score80 / 100
Next earningsWed, Jul 8, 2026 (13d)
EPS forecast−$0.73 · 6 est
Last EPS vs est−$0.79 vs −$0.76
Last surprise-4.0% miss
Setup gradeA+
Conviction96 / 100
Pattern quality—
Tech rank89.4 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance18.56
Support14.66
Days since event—
Candle confirm—
News sentiment—

Financials as of Sat, Feb 28, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in NRIX

All disclosures →
No recent disclosed trades by Congress in NRIX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NRIX · 4 buys · 6 sells

InsiderSideShares
Hansen Gwenn
Chief Scientific Officer · Common Stock · 2026-06-25
Sell5.39K
Ring Christine
Chief Legal Officer · Common Stock · 2026-06-25
Exercise13.33K
Ring Christine
Chief Legal Officer · Common Stock · 2026-06-25
Exercise15.6K
Ring Christine
Chief Legal Officer · Common Stock · 2026-06-25
Sell28.93K
Ring Christine
Chief Legal Officer · Employee Stock Option (right to buy) · 2026-06-25
Exercise13.33K
Ring Christine
Chief Legal Officer · Employee Stock Option (right to buy) · 2026-06-25
Exercise15.6K
Ring Christine
Chief Legal Officer · Employee Stock Option (right to buy) · 2026-06-02
Exercise3.42K
Ring Christine
Chief Legal Officer · Common Stock · 2026-06-02
Sell8.15K
Ring Christine
Chief Legal Officer · Common Stock · 2026-06-02
Exercise3.42K
GREGORY JULIA P
Director · Director Stock Option (right to buy) · 2026-05-15
Grant31.25K

SEC filings

EDGAR filings in NRIX · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.